Adverse Events of SARS-CoV-2 Therapy: A Pharmacovigilance Study of the FAERS Database
Description
CONCLUSIONS AND RELEVANCE: This is the first retrospective study done on reported AEs associated with nirmatrelvir/ritonavir use for COVID-19. COVID-19 and disease recurrence were the most reported AEs. Further monitoring of the FAERS database is